RE:RE:Cool!99942Apophis wrote: This is surprisingly revealing to Theralase's plan in my opinion only to not only go into commercialization in Canada & US but internationally i.e. Europe perhaps Asia and other countries where Theralase has patents filed. It appears TLT might be looking for more than one partner to enter commercialization which makes perfect sense as no one single company will be able to use leverage.
Exciting, yes.
Dr. Lbiati stated that, "I am very excited to finally get involved with the Canadian biotech ecosystem and I look forward to assisting Theralase® achieve its strategic objectives of commercialization through partnering of its lead pharmaceutical drug with large pharmaceutical organizations in North America and internationally. Theralase® is at an inflection point in its drug development pipeline and I believe this highly promising Canadian-born Anti-Cancer Therapy ("ACT") is on the verge of demonstrating to the world the safety and efficacy that this platform truly bring to patients inflicted with cancer; firstly for patients diagnosed with Bacillus Calmette-Gurin ("BCG")-Unresponsive Non-Muscle Invasive Bladder Cancer ("NMIBC"), who are running out of therapeutic options and are facing bladder removal surgery."
Not quite the news I've been waiting for all these years, but positive and encouraging nonetheless.
Fingers and toes still crossed that this goes all the way.
Coop